So, meals are digested more slowly, which lowers the rise in blood sugar after a meal
Furthermore, a study of patients with type 2 diabetes who were treated with once-weekly exenatide found significant reductions in weight regardless of whether patients experienced nausea or vomiting [53]
GLP-1 medications have changed the conversation around weight loss by addressing these biological factors directly
Although these findings offer reassurance regarding the safety of these drugs, further validation is essential
Tirzepatide (Mounjaro and Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss in clinical trials compared to semaglutide
Beyond changes in calorie intake, only eight studies, to date, have evaluated changes in macronutrient intake in GLP-1 RA users